-August 4, 2005: For Immediate Release-
Parkinson’s Drug Causes Obsessive Compulsive Behaviors
Welch, Brewer and Hudson, LLC
and The Law Offices of Darren
O’Quinn have filed a law suit on behalf of Shelia
Elrod, 49, a resident
of Little Rock alleging that the drug
Mirapex, marketed by
and other companies causes destructive obsessive compulsive
behaviors including gambling in persons not otherwise
predisposed to engage in those behaviors.
A series of studies indicate that
and other drugs in a class of drugs known as “dopamine agonists”
caused such obsessive-compulsive behaviors. In 2002-03, a study
at the prestigious Mohamed Ali Center for Parkinson’s Research
in Arizona concluded that the drug likely caused such obsessive
compulsive gambling in a significant number of patients. That
study was published in the journal
Neurology in 2003.
In July 2005, a Mayo clinic study reached similar conclusions.
While denying any connection to
the drug, Pfizer changed its package insert in 2005 to include
the ‘slight risk’ of patients developing compulsive behaviors
such as gambling.
In the lawsuit filed in Pulaski
Circuit Court on Thursday, Ms. Elrod alleges that before being
prescribed Mirapex by her physician, she had not been a
compulsive gambler and had had very limited exposure to gambling
at all for less than $50, total. Ms. Elrod says that her
dosages after being raised above a certain limit caused her to
surreptitiously engage in gambling behaviors that cost her and
her family over $400,000 in a period of less than 18 months.
Once the drug was
discontinued, all gambling behavior ceased, the suit said.
Morgan E. “Chip” Welch
of Welch, Brewer and Hudson
and Darren O’Quinn
of the O’Quinn Law Firm,
lawyers for Elrod, stated that the pharmaceutical companies were
aware of statistically significant instances of patients
suffering obsessive compulsive gambling and had a duty to warn
patients of the dangers associated with the drug.
information or a copy of the complaint, contact
Morgan E. “Chip” Welch at